Abstract
The effects of the calcium antagonist, felodipine, and hydrochlorothiazide (HCTZ) on natriuresis/diuresis and blood pressure were evaluated in 12 healthy subjects. The investigation was designed as a double-blind, three-way, randomised, crossover study, and all comparisons were performed against placebo. Urine volume, urine sodium excretion, heart rate and blood pressure were measured after a single dose of felodipine 10 mg, HCTZ 12.5 mg or placebo as well as during steady-state conditions (6 days of treatment with felodipine 10 mg b.i.d., HCTZ 12.5 mg b.i.d. or placebo).
A significant increase in natriuresis was seen in the first 4 h after a single dose of felodipine and HCTZ, and the effect of felodipine was approximately 40% that of HCTZ. When the entire 24-h period after a single dose was studied, there was a significant increase in natriuresis after HCTZ, but not after felodipine, compared with placebo.
A significant increase in diuresis was found in the first 4 h after a single dose of HCTZ, but not after felodipine, compared with placebo.
Under steady-state conditions, there were no statistically significant differences between felodipine and placebo or HCTZ and placebo when the 24-h period, as a whole was considered.
Potassium excretion was not affected by any of the drugs. Felodipine caused a significant decrease in diastolic blood pressure in this study. This was not the case for HCTZ or placebo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahnoff M (1984) Determination of felodipine in plasma by capillary gas chromatography with electron capture detection. J Pharm Biomed Anal 2: 519–526
Beermann B, Groschinsky-Grind M (1977) Pharmacokinetics of hydrochlorothiazide in man. Eur J Clin Pharmacol 2: 297–303
Bengtsson-Hasselgren B, Edgar B, Rönn O (1988) Dosëdependent effects of felodipine on diuresis and natriuresis in healthy subjects. J Cardiovasc Pharmacol 12: 134–139
Bengtsson-Hasselgren B, Elmfeldt D, Moberg L, Rönn O (1989) Haemodynamic effects and pharmacokinetics of felodipine at rest and during exercise in hypertensive patients treated with metoprolol or atenolol. Eur J Clin Pharmacol 37: 459–465
Dibona GF, Sawin LL (1984) Renal tubular site of action of felodipine. J Pharmacol Exp Ther 228: 420–424
Edgar B, Bengtsson B, Elmfeldt D, Lundborg P, Nyberg G, Raner S, Rönn O (1985) Acute diuretic/natriuretic properties of felodipine in man. Drugs 2: 176–184
Ene MD, Williamson PJ, Roberts CJ, Waddell G (1985) The natriuresis following renal administration of the calcium antagonists-nifedipine and nitrendipine. Br J Clin Pharmacol 19: 423–427
Ervik M, Gustavii K (1974) Application of the extractive alkylation technique to the gas chromatographic determination of chlorthalidone in plasma in nanogram quantities. Anal Chem 46: 39–42
Faulds D, Sorkin EM (1992) Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients. Drugs Aging 2: 374–388
Gustafsson D (1987) Microvascular mechanisms involved in calcium antagonist edema formation. J Cardiovasc Pharmacol 10: S121–131
Hasselgren B, Rönn O, Edgar B, Johansson P, Wall B (1990) Pharmacokinetics and hemodynamic and diuretic/natriuretic effects of felodipine administered as an extended-release tablet. Cardiovasc Drugs Ther 4: 1495–1500
Hulthen UL, Katzman PL (1988) Renal effects of acute and long-term treatment with felodipine in essential hypertension. J Hypertens 6: 231–237
Larochelle P (1992) Renal tubular effects of calcium antagonists. Kidney Int [Suppl] 36: 49–53
Leonetti G, Gradnik R, Terzoli L, Frusio M, Rupoli L, Cuspidi C, Sampieri L, Zanchetti A (1986) Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients. J Cardiovasc Pharmacol 8: 1243–1248
Linas SL, Nies AS (1981) Minoxidil. Ann Intern Med 94: 61–65
Ljung B (1985) Vascular selectivity of felodipine. Drugs 2: 46–58
Morgan TO, Anderson A (1992) Hemodynamic comparisons of enalapril and felodipine and their combination. Kidney Int [Suppl] 36: S78–81
Nordlander M, Di Bona GF, Ljung B, Yao T, Thorén P (1985) Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR. Eur J Pharmacol 113: 25–36
Pettersson A, Hedner J, Hedner T, Held P, Swedberg K, Towle AC (1986) Increased plasma levels of atrial natriuretic peptide in patients with congestive heart failure. Eur Heart J 7: 693–696
Reyes AJ, Leary WP (1993) Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations. Cardiovasc Drugs Ther 1: 29–44
Saltiel E, Ellrodt AG, Monk JP, Langley MS (1988) Felodipine. A review of its pharmacodynamic and pharmacokineetic properties, and therapeutic use in hypertension. Drugs 36: 387–428
Shamiss A, Peleg E, Rosenthal T, Ezra D (1993) The role of atrial natriuretic peptide in the diuretic effect of Ca2+ entry blockers. Eur J Pharmacol 233: 113–117
Sluiter HE, Huysmans FT, Thien TA, Koene RA (1985) Haemodynamics effects of intravenous felodipine in normotensive and hypertensive subjects. Drugs 2: 144–153
Watanabe TX, Shiono K, Saito K, Sokabe H (1978) Antihypertensive and antidiuretic effects of 3-hydrazino-6-: N, N-bis (2-hydroxyethyl) amino:-pyridazine (L 6150) in rats. Jpn J Pharmacol 28: 413–422
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hasselgren, B., Johansson, P. Natriuretic and diuretic effects of felodipine and hydrochlorothiazide after single and repeated doses. Eur J Clin Pharmacol 47, 395–400 (1995). https://doi.org/10.1007/BF00196851
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00196851